FDA Authorizes Third Combination Diagnostic Test for Flu and COVID-19

July 06, 2020

The FDA has granted emergency use authorization to an additional combination diagnostic test for influenza and COVID-19.

FDA Guidance Provides Safety, Quality Standards for COVID-19 Vaccine Development

June 30, 2020

In a new guidance, the FDA provides recommendations for those developing COVID-19 vaccines to ensure safety and efficacy.

Part 2: A Conversation on Remdesivir Trial Updates

June 29, 2020

Julie Ann Justo, infectious diseases clinical pharmacist and associate professor at the University of South Carolina College of Pharmacy, discusses the latest data from Gilead's trials for Remdesivir, a potential COVID-19 treatment.

Children’s Cough Relief Products Recalled for Wrong Dosing Cups

June 23, 2020

The FDA warned that the dosing cups, which were missing some graduation markings, could cause an accidental overdose.

CDC Urges Routine Vaccinations Despite COVID-19 Pandemic

June 17, 2020

The CDC released an updated vaccination guidance on administering routine vaccinations amid the coronavirus disease 2019 (COVID-19) pandemic.

FDA Revokes EUA for Chloroquine and Hydroxychloroquine

June 15, 2020

Since the emergency use authorization was granted, new data on heart risks associated with hydroxychloroquine and chloroquine have been revealed.

Pharmacies Prepare For Possible Surge In Flu Vaccinations This Season

June 15, 2020

Pharmacies are preparing for what is expected to be a surge in flu vaccinations this year as Americans are putting a greater focus on staying healthy amid the coronavirus pandemic.

FDA OKs Antibiotic for Hospital-Acquired and Ventilator-Associated Bacterial Pneumonia

June 08, 2020

Officials with the FDA have approved imipenem, cilastatin, and relebactam (Recarbrio, Merck) for the treatment of adults with hospital-acquired and ventilator-associated bacterial pneumonia. 

Drug Interaction Concerns for Potential COVID-19 Treatments

May 22, 2020

A close look at their potential to interact with other medications is required to limit the risk of adverse outcomes for patients.

Investigational Drugs in the Pipeline for COVID-19

May 12, 2020

Investigators are evaluating a variety of medications for the novel coronavirus disease 2019 (COVID- 19), and the possible treatment landscape is rapidly evolving.